Tohru Sugimoto

PPM1D is a potential target for 17q gain in neuroblastoma.

Fumiko Saito-Ohara, Issei Imoto, Jun Inoue et al. · PubMed · 2003 · 232 citations

Medicine, Genetics, Molecular Genetics +14

Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice

Koichi Tanda, Akinori Nishi, Naoki Matsuo et al. · Molecular Brain · 2009 · 132 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study

Eiso Hiyama, Tomoko Iehara, Tohru Sugimoto et al. · The Lancet · 2008 · 126 citations

Medicine, Oncology, Pediatrics +6

Murine neocortical histogenesis is perturbed by prenatal exposure to low doses of bisphenol A

Keiko Nakamura, Kyoko Itoh, Takeshi Yaoi et al. · Journal of Neuroscience Research · 2006 · 124 citations

Life Sciences, Developmental Biology, Neuroscience +17

Prediction of <i>MYCN</i> Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain Reaction

Takahiro Gotoh, Hajime Hosoi, Tomoko Iehara et al. · Journal of Clinical Oncology · 2005 · 94 citations · Full text

Medicine, Molecular Genetics, Oncology +15